Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 inï¿½vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 inï¿½vitro

Published:2018-02-01 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Yang Yanhong¹,Zhou Wenwen¹,Wu Jiandong¹,Yao Lixin¹,Xue Lei¹,Zhang Qianyi²,Wang Zhenzhen¹,Wang Xiaoyu³,Dong Shu⁴,Zhao Jiangman⁴,Yin Duanduan¹

Affiliation:

1. Department of Oncology, Qinhuangdao No. 1 People's Hospital, Qinhuangdao, Hebei 066000, P.R. China

2. College of Pharmacy, University of Tasmania, Hobart, TAS 7001, Australia

3. Postgraduate College of Chengde Medical University, Chengde, Hebei 067000, P.R. China

4. Biotecan Medical Diagnostics Co., Ltd., Shanghai 201203, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma;Carcinogenesis;2023-06-01

2. Oxidized tea polyphenol (OTP-3) targets EGFR synergistic nimotuzumab at inhibition of non-small cell lung tumor growth;Bioorganic Chemistry;2022-11

3. Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy;International Journal of Nanomedicine;2022-08

4. Synthesis of 111In-p-SCN-Bn-DTPA-nimotuzumab and its preclinical evaluation in EGFR positive NSCLC animal model;Radiochimica Acta;2021-10-20

5. Stable W/O/W multiple nanoemulsion encapsulating natural tocotrienols and caffeic acid with cisplatin synergistically treated cancer cell lines (A549 and HEP G2) and reduced toxicity on normal cell line (HEK 293);Materials Science and Engineering: C;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3